SCHEMBL30452839

SCHEMBL30452839

NCCc1ccc2cnccc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.51
LOXL2 Q9Y4K0 1/20 0.50
CHRNA7 P36544 1/20 0.48
TBXAS1 P24557 1/20 0.44
PRKCZ Q05513 1/20 0.43
MELK Q14680 1/20 0.43
ROCK1 Q13464 7/20 0.41
ROCK2 O75116 2/20 0.41
TAAR1 Q96RJ0 2/20 0.41
KDM4E B2RXH2 2/20 0.41
ADRA2A P08913 2/20 0.41
MAPT P10636 2/20 0.41
DRD2 P14416 2/20 0.41
DRD1 P21728 2/20 0.41
DRD4 P21917 2/20 0.41
DRD5 P21918 2/20 0.41
SLC6A2 P23975 2/20 0.41
MAPK1 P28482 2/20 0.41
DRD3 P35462 2/20 0.41
RECQL P46063 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23291124 1.00 CYP19A1 (0.51) CYP19A1LOXL2CHRNA7TBXAS1PRKCZ
SCHEMBL3127988 0.85 CYP19A1 (0.51) CYP19A1TBXAS1MELKROCK1ROCK2
SCHEMBL31472893 0.85 CYP19A1 (0.54) CYP19A1LOXL2TBXAS1PRKCZMELK
SCHEMBL5801109 0.85 CYP19A1 (0.54) CYP19A1LOXL2TBXAS1PRKCZMELK
Hydrochloric Acid SCHEMBL29243533 0.83 CYP19A1 (0.53) CYP19A1LOXL2TBXAS1PRKCZMELK
SCHEMBL27503273 0.81 CYP19A1 (0.51) CYP19A1TBXAS1PRKCZMELKROCK1
SCHEMBL3128985 0.81 CYP19A1 (0.51) CYP19A1TBXAS1MELKROCK1ROCK2
SCHEMBL6114451 0.81 CYP19A1 (0.51) CYP19A1TBXAS1
SCHEMBL31349743 0.81 CYP19A1 (0.51) CYP19A1TBXAS1
Hydrochloric Acid SCHEMBL6563371 0.80 KDM4E (0.58) TAAR1KDM4EADRA2AMAPTDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111164084-B Triazolotriazine derivatives useful as A2A receptor antagonists 浙江春禾医药科技有限公司 2023-05-23 CN disclosed